- Issuer ticker
-
MYGN
- Reported as of
-
30 Jun 2022
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
30 Jun 2022, 16:37:04 UTC
Reporting owner
1 detail
- Reporting owner signature
-
By: Natalie Munk For: Dennis H. Langer
Key filing fact
Dennis Langer filed Form 4 for MYRIAD GENETICS INC (MYGN) on 30 Jun 2022.
Key facts
- This page summarizes Dennis Langer's Form 4 filing for MYRIAD GENETICS INC (MYGN).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Jun 2022, 16:37.
Change
- Previous filing in this sequence was filed on 03 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MYGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 106,802
- Date
- 30 Jun 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MYGN
holding
Derivative
Non-Qualified Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 30,000
- Date
- 30 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $27.61
* marks a reported price that did not pass the local price check.
Section 16 status
Dennis Langer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
SEC remarks
This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a Company Board of Director, effective June 30, 2022, and therefore is no longer subject to Section 16 reporting.